Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neal Walker Insider Profile
4 Followers
Neal Walker, Director at Aldeyra Therapeutics, holds 1.29M shares in Aclaris Therapeutics (Ticker: ACRS), holds 15.85K shares in Aldeyra Therapeutics (Ticker: ALDX).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-1.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Neal Walker holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 14, 2022 - Mar 14, 2023
Return:+43.40%
The most profitable trade made by Neal Walker
Neal Walker's Trading History
Aldeyra Therapeutics
Aug 24, 2023
Director
Informative Buy
5.28K
$62.31K
Aclaris Therapeutics
Apr 03, 2024
INTERIM PRESIDENT AND CEO, Director
Uninformative Buy
4.06K
$1.54M
List of latest transactions for each holding click on a transaction to see Neal Walker's performance on stock
You May Also Like
Neal Walker insider profile FAQ
What is the percentage of profitable transactions made by Neal Walker?
The percentage of profitable transactions made by Neal Walker is 50%.
What is the average return per transaction made by Neal Walker?
The average return per transaction made by Neal Walker is -1.80%.
What stocks does Neal Walker hold?
Neal Walker holds: ALDX, ACRS stocks.
What was Neal Walker’s latest transaction?
Neal Walker latest transaction was an Uninformative Buy of $4.06K.
What was Neal Walker's most profitable transaction?
Neal Walker’s most profitable transaction was an Informative Sell of ACRS stock on March 14, 2022. The return on the trade was 43.40%.
What is Neal Walker's role in Aldeyra Therapeutics?
Neal Walker's role in Aldeyra Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.